These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6773191)

  • 41. Mechanisms for Hageman factor activation and role of HMW kininogen as a coagulation cofactor.
    Kaplan AP; Silverberg M; Dunn JT; Miller G
    Ann N Y Acad Sci; 1981; 370():253-60. PubMed ID: 6455951
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Surface activation of blood coagulation, fibrinolysis and kinin formation.
    Heimark RL; Kurachi K; Fujikawa K; Davie EW
    Nature; 1980 Jul; 286(5772):456-60. PubMed ID: 6447254
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Kinetics of activation of prekallikrein by prekallikrein activator.
    Tankersley DL; Fournel MA; Schroeder DD
    Biochemistry; 1980 Jul; 19(14):3121-7. PubMed ID: 6967731
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A quarter century with Mr. Hageman.
    Ratnoff OD
    Thromb Haemost; 1980 Jun; 43(2):95-8. PubMed ID: 7006141
    [No Abstract]   [Full Text] [Related]  

  • 45. Prekallikrein activation and high-molecular-weight kininogen consumption in hereditary angioedema.
    Schapira M; Silver LD; Scott CF; Schmaier AH; Prograis LJ; Curd JG; Colman RW
    N Engl J Med; 1983 May; 308(18):1050-3. PubMed ID: 6601240
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents.
    España F; Ratnoff OD
    J Lab Clin Med; 1983 Oct; 102(4):487-99. PubMed ID: 6604770
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The IgE-dependent release of a Hageman factor cleaving factor from human lung.
    Meier HL; Flowers B; Silverberg M; Kaplan AP; Newball HH
    Am J Pathol; 1986 Apr; 123(1):146-54. PubMed ID: 3634571
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Activation of kinin-prekallikrein system after infusion of factor VIII concentrates in hemophilic patients.
    Alegre A; Alberca I; Vicente V
    Clin Ther; 1986; 9(1):92-6. PubMed ID: 3102070
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunochemical studies of plasma kallikrein.
    Bagdasarian A; Lahiri B; Talamo RC; Wong P; Colman RW
    J Clin Invest; 1974 Dec; 54(6):1444-54. PubMed ID: 4140197
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The bradykinin-forming cascade: a historical perspective.
    Kaplan AP
    Chem Immunol Allergy; 2014; 100():205-13. PubMed ID: 24925400
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activation of human Hageman factor by a leukocytic protease.
    Newball HH; Revak SD; Cochrane CG; Griffin JH; Lichtenstein LM
    Adv Exp Med Biol; 1979; 120B():139-51. PubMed ID: 517231
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of high-molecular-weight kininogen in surface-binding and activation of coagulation Factor XI and prekallikrein.
    Wiggins RC; Bouma BN; Cochrane CG; Griffin JH
    Proc Natl Acad Sci U S A; 1977 Oct; 74(10):4636-40. PubMed ID: 270705
    [TBL] [Abstract][Full Text] [Related]  

  • 53. One-step preparation of Hageman factor fragment concentrate.
    Simonianová E
    Biomed Chromatogr; 1992; 6(4):194-5. PubMed ID: 1643388
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enzymatic activities of activated and zymogen forms of human Hageman factor (factor XII).
    Silverberg M; Kaplan AP
    Blood; 1982 Jul; 60(1):64-70. PubMed ID: 6979361
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Binding and dissociation of Hageman factor, prekallikrein and high molecular weight kininogen in human plasma during contact activation.
    Nakahara M
    Biochem Pharmacol; 1980 May; 29(9):1247-54. PubMed ID: 6772195
    [No Abstract]   [Full Text] [Related]  

  • 56. Activation of human Hageman factor (factor XII) in the presence of zinc and phosphate ions.
    Shibayama Y; Brunnee T; Kaplan AP; Reddigari S
    Braz J Med Biol Res; 1994 Aug; 27(8):1817-28. PubMed ID: 7749371
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cytokine and estrogen stimulation of endothelial cells augments activation of the prekallikrein-high molecular weight kininogen complex: Implications for hereditary angioedema.
    Joseph K; Tholanikunnel BG; Kaplan AP
    J Allergy Clin Immunol; 2017 Jul; 140(1):170-176. PubMed ID: 27826093
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Activation of factor XII and prekallikrein with cholesterol sulfate.
    Shimada T; Kato H; Iwanaga S; Iwamori M; Nagai Y
    Thromb Res; 1985 Apr; 38(1):21-31. PubMed ID: 3847226
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The first component of the kinin-forming system in human and rabbit plasma. Its relationship to clotting factor XII (Hageman Factor).
    Cochrane CG; Wuepper KD
    J Exp Med; 1971 Oct; 134(4):986-1004. PubMed ID: 4106492
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hageman factor-dependent pathways: mechanism of initiation and bradykinin formation.
    Kaplan AP
    Fed Proc; 1983 Nov; 42(14):3123-7. PubMed ID: 6556144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.